BIOMARIN PHARMACEUTICAL INC Annual Return On Equity in % from 2011 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Biomarin Pharmaceutical Inc quarterly/annual Return On Equity history and growth rate from 2011 to 2023.
  • Biomarin Pharmaceutical Inc Return On Equity for the quarter ending September 30, 2024 was 6.22 %, a 100% increase year-over-year.
  • Biomarin Pharmaceutical Inc annual Return On Equity for 2023 was 3.48 %, a 10.8% increase from 2022.
  • Biomarin Pharmaceutical Inc annual Return On Equity for 2022 was 3.14 %.
  • Biomarin Pharmaceutical Inc annual Return On Equity for 2021 was -1.51 %, a 106% decline from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 3.48 +0.34 +10.8% Jan 1, 2023 Dec 31, 2023
2022 3.14 +4.65 Jan 1, 2022 Dec 31, 2022
2021 -1.51 -24.9 -106% Jan 1, 2021 Dec 31, 2021
2020 23.4 +24.1 Jan 1, 2020 Dec 31, 2020
2019 -0.79 +1.88 +70.5% Jan 1, 2019 Dec 31, 2019
2018 -2.67 +1.52 +36.3% Jan 1, 2018 Dec 31, 2018
2017 -4.18 +22 +84% Jan 1, 2017 Dec 31, 2017
2016 -26.2 -19 -261% Jan 1, 2016 Dec 31, 2016
2015 -7.25 +1.74 +19.3% Jan 1, 2015 Dec 31, 2015
2014 -8.99 +4.77 +34.7% Jan 1, 2014 Dec 31, 2014
2013 -13.8 -1.74 -14.5% Jan 1, 2013 Dec 31, 2013
2012 -12 -4.85 -67.6% Jan 1, 2012 Dec 31, 2012
2011 -7.18 Jan 1, 2011 Dec 31, 2011
* An asterisk sign (*) next to the value indicates that the value is likely invalid.